MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual MeetingCHICAGO-- (BUSINESS WIRE)-- MAIA Biotechnology, Inc. (NYSE American: MAIA), a ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics ...

CHICAGO, July 01, 2025--MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress ...

MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an abstract about the ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

PanGIA Biotech Announces Upcoming ASCO 2025 Poster Presentation of Collaborative Research PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today ...

REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that ...

A biotech research and development center announced that they have plans to set up operations in Spartanburg County.

Poster highlights potential predictive biomarker for therapeutic response in advanced non-small cell lung cancer (NSCLC) “We are proud to join ELCC 2025, a premier conference focused directly on ...

MAIA Biotechnology, Inc.,, a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that a late-breaking abstract detailing new updates from its ...

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics Oct. 15, 2024 8:15 AM ET MAIA Biotechnology, Inc. (MAIA) ...

PanGIA Biotech, a company advancing urine-based, AI-driven diagnostics for early cancer detection, today announced that an abstract co-authored by researchers from PanGIA Biotech, Entopsis Inc ...